A generic drug is identified by its chemical name, rather than a trademarked, brand name. Generally, generic drugs are introduced into the market following the patent expiration of innovator brand drugs. All generic distributed in the United States have to have the same active chemical ingredient as the brand-name counterparts, and must go through an approval process through the FDA to be deemed bio equivalent.
Supplier Information
Below are several programs offered to Generic Programs and Services:
Manufacturer Web Portal(Coming soon) – In an effort to gain a better understanding of our supplier partners’ capabilities, this web portal will allow manufacturers to share product lists, R&D capabilities, and strategies in a confidential and secure environment.
PRxO Generics Program (Retail) - As one of the single largest buyer of generics in the nation, AmerisourceBergen is able to bring our customers the most comprehensive portfolio in the industry.